At its current revenue, its priced very expensivly. That can easily change if revenue grows quicker than any additional issuance. Need a few quarters at 40%+ qoq growth. As you said, the latest quarterly was nice.
This thing has tight holders and still has support when needed. Could be that the price is being held low, as big money knows they can dilute small players. Could be anything.
I'm excited and impatient. Which is sad because my happiness will come at the health of someone else. What i know is if this thing gets going, it will have profound intergenerational effects for my family. One can only hope.
- Forums
- ASX - By Stock
- Sales projections
OSL
oncosil medical ltd
Add to My Watchlist
6.84%
!
$1.02

At its current revenue, its priced very expensivly. That can...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.065(6.84%) |
Mkt cap ! $14.43M |
Open | High | Low | Value | Volume |
$1.00 | $1.03 | 96.0¢ | $23.22K | 23.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 1042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 0.950 |
2 | 1349 | 0.940 |
1 | 627 | 0.920 |
1 | 23 | 0.910 |
1 | 20000 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 1042 | 1 |
1.030 | 27 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.080 | 48 | 1 |
Last trade - 14.07pm 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online